Bristol Myers Squibb Stock Price Prediction
BMY Stock | USD 58.87 0.64 1.10% |
Oversold Vs Overbought
71
Oversold | Overbought |
Quarterly Earnings Growth (0.36) | EPS Estimate Next Quarter 1.52 | EPS Estimate Current Year 0.902 | EPS Estimate Next Year 7.0601 | Wall Street Target Price 59.3691 |
Using Bristol Myers hype-based prediction, you can estimate the value of Bristol Myers Squibb from the perspective of Bristol Myers response to recently generated media hype and the effects of current headlines on its competitors.
Bristol Myers Squibb Hype to Price Pattern
Investor biases related to Bristol Myers' public news can be used to forecast risks associated with an investment in Bristol. The trend in average sentiment can be used to explain how an investor holding Bristol can time the market purely based on public headlines and social activities around Bristol Myers Squibb. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Bristol Myers' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Bristol Myers.
The fear of missing out, i.e., FOMO, can cause potential investors in Bristol Myers to buy its stock at a price that has no basis in reality. In that case, they are not buying Bristol because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Bristol Myers after-hype prediction price | USD 59.09 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Bristol |
Bristol Myers After-Hype Price Prediction Density Analysis
As far as predicting the price of Bristol Myers at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Bristol Myers or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Bristol Myers, with the unreliable approximations that try to describe financial returns.
Next price density |
Expected price to next headline |
Bristol Myers Estimiated After-Hype Price Volatility
In the context of predicting Bristol Myers' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Bristol Myers' historical news coverage. Bristol Myers' after-hype downside and upside margins for the prediction period are 57.09 and 61.09, respectively. We have considered Bristol Myers' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Bristol Myers is very steady at this time. Analysis and calculation of next after-hype price of Bristol Myers Squibb is based on 3 months time horizon.
Bristol Myers Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Bristol Myers is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bristol Myers backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Bristol Myers, there might be something going there, and it might present an excellent short sale opportunity.
Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.35 | 2.00 | 0.22 | 0.02 | 8 Events / Month | 7 Events / Month | In about 8 days |
Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
58.87 | 59.09 | 0.37 |
|
Bristol Myers Hype Timeline
On the 25th of November Bristol Myers Squibb is traded for 58.87. The entity has historical hype elasticity of 0.22, and average elasticity to hype of competition of -0.02. Bristol is expected to increase in value after the next headline, with the price projected to jump to 59.09 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 0.37%, whereas the daily expected return is currently at 0.35%. The volatility of related hype on Bristol Myers is about 3214.29%, with the expected price after the next announcement by competition of 58.85. The company reported the last year's revenue of 45.01 B. Total Income to common stockholders was 8.04 B with profit before taxes, overhead, and interest of 36.38 B. Considering the 90-day investment horizon the next expected press release will be in about 8 days. Check out Bristol Myers Basic Forecasting Models to cross-verify your projections.Bristol Myers Related Hype Analysis
Having access to credible news sources related to Bristol Myers' direct competition is more important than ever and may enhance your ability to predict Bristol Myers' future price movements. Getting to know how Bristol Myers' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Bristol Myers may potentially react to the hype associated with one of its peers.
HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
CAPR | Capricor Therapeutics | (0.08) | 11 per month | 4.10 | 0.23 | 18.22 | (7.37) | 69.31 | |
SLNO | Soleno Therapeutics | 0.67 | 10 per month | 2.49 | 0.06 | 6.31 | (4.12) | 13.33 | |
BPTH | Bio Path Holdings | (0.01) | 8 per month | 0.00 | (0.09) | 6.67 | (8.08) | 51.22 | |
MBRX | Moleculin Biotech | (0.20) | 9 per month | 4.27 | 0.04 | 9.75 | (7.01) | 35.41 | |
CRNX | Crinetics Pharmaceuticals | 1.32 | 9 per month | 2.43 | (0.01) | 3.67 | (3.45) | 16.75 | |
ASMB | Assembly Biosciences | (0.45) | 8 per month | 4.46 | 0.01 | 8.49 | (5.34) | 24.80 | |
TIL | Instil Bio | (1.77) | 9 per month | 6.84 | 0.12 | 20.63 | (10.89) | 105.83 | |
CTMX | CytomX Therapeutics | (0.01) | 10 per month | 0.00 | (0.15) | 5.00 | (5.22) | 20.61 | |
ACHL | Achilles Therapeutics PLC | (0.03) | 4 per month | 1.53 | 0.11 | 3.06 | (2.88) | 38.16 |
Bristol Myers Additional Predictive Modules
Most predictive techniques to examine Bristol price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Bristol using various technical indicators. When you analyze Bristol charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
About Bristol Myers Predictive Indicators
The successful prediction of Bristol Myers stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Bristol Myers Squibb, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Bristol Myers based on analysis of Bristol Myers hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Bristol Myers's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Bristol Myers's related companies. 2021 | 2022 | 2023 | 2024 (projected) | Dividend Yield | 0.0317 | 0.0302 | 0.0447 | 0.0374 | Price To Sales Ratio | 2.99 | 3.32 | 2.36 | 2.98 |
Story Coverage note for Bristol Myers
The number of cover stories for Bristol Myers depends on current market conditions and Bristol Myers' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Bristol Myers is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Bristol Myers' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Bristol Myers Short Properties
Bristol Myers' future price predictability will typically decrease when Bristol Myers' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Bristol Myers Squibb often depends not only on the future outlook of the potential Bristol Myers' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bristol Myers' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 2.1 B | |
Cash And Short Term Investments | 12.3 B |
Additional Tools for Bristol Stock Analysis
When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.